ACOR Annual Gross Profit
$102.35 M
+$14.12 M+16.00%
31 December 2023
Summary:
As of February 1, 2025, ACOR annual gross profit is $102.35 million, with the most recent change of +$14.12 million (+16.00%) on December 31, 2023. During the last 3 years, it has fallen by -$17.10 million (-14.32%).ACOR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Quarterly Gross Profit
$16.58 M
-$15.80 M-48.80%
31 March 2024
Summary:
As of February 1, 2025, ACOR quarterly gross profit is $16.58 million, with the most recent change of -$15.80 million (-48.80%) on March 31, 2024. Over the past year, it has dropped by -$2.44 million (-12.84%).ACOR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR TTM Gross Profit
$99.91 M
-$2.44 M-2.39%
31 March 2024
Summary:
As of February 1, 2025, ACOR TTM gross profit is $99.91 million, with the most recent change of -$2.44 million (-2.39%) on March 31, 2024. Over the past year, it has increased by +$9.22 million (+10.16%).ACOR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.0% | -12.8% | +10.2% |
| 3 y3 years | -14.3% | -1.9% | -10.9% |
| 5 y5 years | -72.6% | -53.1% | -36.6% |
ACOR Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -78.5% | -89.7% | -79.5% |
Acorda Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $16.58 M(-48.8%) | $99.91 M(-2.4%) |
| Dec 2023 | $102.35 M(+16.0%) | $32.39 M(+33.1%) | $102.35 M(+5.7%) |
| Sept 2023 | - | $24.33 M(-8.6%) | $96.87 M(+1.9%) |
| June 2023 | - | $26.61 M(+39.9%) | $95.05 M(+4.8%) |
| Mar 2023 | - | $19.02 M(-29.3%) | $90.69 M(+2.8%) |
| Dec 2022 | $88.23 M(-0.1%) | $26.91 M(+19.6%) | $88.23 M(-6.2%) |
| Sept 2022 | - | $22.51 M(+1.1%) | $94.09 M(+4.9%) |
| June 2022 | - | $22.25 M(+34.3%) | $89.74 M(+2.0%) |
| Mar 2022 | - | $16.57 M(-49.4%) | $87.95 M(-0.4%) |
| Dec 2021 | $88.28 M(-26.1%) | $32.77 M(+80.5%) | $88.28 M(+6.6%) |
| Sept 2021 | - | $18.15 M(-11.3%) | $82.83 M(-21.6%) |
| June 2021 | - | $20.46 M(+21.1%) | $105.60 M(-5.8%) |
| Mar 2021 | - | $16.90 M(-38.1%) | $112.10 M(-6.2%) |
| Dec 2020 | $119.45 M(-24.2%) | $27.32 M(-33.2%) | $119.45 M(-10.8%) |
| Sept 2020 | - | $40.92 M(+51.8%) | $133.97 M(+0.9%) |
| June 2020 | - | $26.96 M(+11.1%) | $132.78 M(-9.4%) |
| Mar 2020 | - | $24.26 M(-42.0%) | $146.48 M(-7.0%) |
| Dec 2019 | $157.56 M(-57.8%) | $41.83 M(+5.3%) | $157.56 M(-3.6%) |
| Sept 2019 | - | $39.74 M(-2.3%) | $163.41 M(-32.3%) |
| June 2019 | - | $40.66 M(+15.0%) | $241.33 M(-25.4%) |
| Mar 2019 | - | $35.34 M(-25.9%) | $323.60 M(-13.4%) |
| Dec 2018 | $373.79 M(-21.5%) | $47.68 M(-59.5%) | $373.79 M(-23.4%) |
| Sept 2018 | - | $117.66 M(-4.3%) | $487.88 M(+1.4%) |
| June 2018 | - | $122.92 M(+43.7%) | $481.13 M(+2.8%) |
| Mar 2018 | - | $85.53 M(-47.1%) | $467.82 M(-1.8%) |
| Dec 2017 | $476.33 M(+15.8%) | $161.76 M(+45.8%) | $476.33 M(+12.1%) |
| Sept 2017 | - | $110.91 M(+1.2%) | $424.83 M(+0.7%) |
| June 2017 | - | $109.61 M(+16.6%) | $421.73 M(+2.1%) |
| Mar 2017 | - | $94.04 M(-14.7%) | $412.98 M(+0.4%) |
| Dec 2016 | $411.49 M(+2.9%) | $110.26 M(+2.3%) | $411.49 M(+1.5%) |
| Sept 2016 | - | $107.81 M(+6.9%) | $405.58 M(-3.7%) |
| June 2016 | - | $100.86 M(+9.0%) | $421.06 M(+2.4%) |
| Mar 2016 | - | $92.56 M(-11.3%) | $411.04 M(+2.8%) |
| Dec 2015 | $399.73 M(+24.6%) | $104.34 M(-15.4%) | $399.73 M(+3.0%) |
| Sept 2015 | - | $123.30 M(+35.7%) | $388.12 M(+10.9%) |
| June 2015 | - | $90.84 M(+11.8%) | $350.05 M(+3.8%) |
| Mar 2015 | - | $81.25 M(-12.4%) | $337.28 M(+5.1%) |
| Dec 2014 | $320.87 M | $92.74 M(+8.8%) | $320.87 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $85.23 M(+9.2%) | $302.18 M(+6.2%) |
| June 2014 | - | $78.07 M(+20.4%) | $284.50 M(+2.9%) |
| Mar 2014 | - | $64.83 M(-12.5%) | $276.39 M(+2.4%) |
| Dec 2013 | $269.79 M(+8.7%) | $74.06 M(+9.6%) | $269.78 M(+3.4%) |
| Sept 2013 | - | $67.55 M(-3.4%) | $260.84 M(+2.0%) |
| June 2013 | - | $69.96 M(+20.2%) | $255.81 M(+3.2%) |
| Mar 2013 | - | $58.22 M(-10.6%) | $247.77 M(-0.2%) |
| Dec 2012 | $248.17 M(+10.0%) | $65.11 M(+4.1%) | $248.17 M(+2.5%) |
| Sept 2012 | - | $62.52 M(+1.0%) | $242.12 M(-0.8%) |
| June 2012 | - | $61.92 M(+5.6%) | $244.07 M(+3.8%) |
| Mar 2012 | - | $58.63 M(-0.7%) | $235.22 M(+4.2%) |
| Dec 2011 | $225.67 M(+45.8%) | $59.05 M(-8.4%) | $225.67 M(+2.4%) |
| Sept 2011 | - | $64.47 M(+21.5%) | $220.31 M(+6.1%) |
| June 2011 | - | $53.07 M(+8.1%) | $207.63 M(+9.5%) |
| Mar 2011 | - | $49.08 M(-8.6%) | $189.56 M(+22.2%) |
| Dec 2010 | $154.83 M(+255.0%) | $53.69 M(+3.7%) | $155.16 M(+37.4%) |
| Sept 2010 | - | $51.79 M(+48.0%) | $112.96 M(+53.1%) |
| June 2010 | - | $35.00 M(+138.6%) | $73.78 M(+52.5%) |
| Mar 2010 | - | $14.67 M(+27.6%) | $48.38 M(+10.9%) |
| Dec 2009 | $43.61 M(+19.6%) | $11.49 M(-8.9%) | $43.61 M(+4.5%) |
| Sept 2009 | - | $12.61 M(+31.4%) | $41.74 M(+7.3%) |
| June 2009 | - | $9.60 M(-3.1%) | $38.90 M(+2.8%) |
| Mar 2009 | - | $9.91 M(+3.0%) | $37.85 M(+3.8%) |
| Dec 2008 | $36.47 M(+17.2%) | $9.62 M(-1.4%) | $36.47 M(+2.9%) |
| Sept 2008 | - | $9.76 M(+14.1%) | $35.45 M(+4.4%) |
| June 2008 | - | $8.56 M(+0.3%) | $33.97 M(+3.3%) |
| Mar 2008 | - | $8.53 M(-0.9%) | $32.89 M(+5.7%) |
| Dec 2007 | $31.13 M(+53.9%) | $8.61 M(+4.0%) | $31.13 M(+14.6%) |
| Sept 2007 | - | $8.28 M(+10.6%) | $27.16 M(+15.8%) |
| June 2007 | - | $7.48 M(+10.7%) | $23.46 M(-3.2%) |
| Mar 2007 | - | $6.76 M(+45.9%) | $24.23 M(+19.8%) |
| Dec 2006 | $20.23 M(>+9900.0%) | $4.63 M(+1.3%) | $20.23 M(+30.9%) |
| Sept 2006 | - | $4.58 M(-44.6%) | $15.45 M(+20.6%) |
| June 2006 | - | $8.26 M(+199.4%) | $12.81 M(+181.5%) |
| Mar 2006 | - | $2.76 M(-2010.2%) | $4.55 M(+153.9%) |
| Dec 2005 | $13.40 K(-100.3%) | -$144.40 K(-107.5%) | $1.79 M(-7.5%) |
| Sept 2005 | - | $1.94 M | $1.94 M |
| Dec 2004 | -$4.82 M(-663.4%) | - | - |
| Dec 2003 | $856.00 K | - | - |
FAQ
- What is Acorda Therapeutics annual gross profit?
- What is the all time high annual gross profit for Acorda Therapeutics?
- What is Acorda Therapeutics annual gross profit year-on-year change?
- What is Acorda Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly gross profit year-on-year change?
- What is Acorda Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Acorda Therapeutics?
- What is Acorda Therapeutics TTM gross profit year-on-year change?
What is Acorda Therapeutics annual gross profit?
The current annual gross profit of ACOR is $102.35 M
What is the all time high annual gross profit for Acorda Therapeutics?
Acorda Therapeutics all-time high annual gross profit is $476.33 M
What is Acorda Therapeutics annual gross profit year-on-year change?
Over the past year, ACOR annual gross profit has changed by +$14.12 M (+16.00%)
What is Acorda Therapeutics quarterly gross profit?
The current quarterly gross profit of ACOR is $16.58 M
What is the all time high quarterly gross profit for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly gross profit is $161.76 M
What is Acorda Therapeutics quarterly gross profit year-on-year change?
Over the past year, ACOR quarterly gross profit has changed by -$2.44 M (-12.84%)
What is Acorda Therapeutics TTM gross profit?
The current TTM gross profit of ACOR is $99.91 M
What is the all time high TTM gross profit for Acorda Therapeutics?
Acorda Therapeutics all-time high TTM gross profit is $487.88 M
What is Acorda Therapeutics TTM gross profit year-on-year change?
Over the past year, ACOR TTM gross profit has changed by +$9.22 M (+10.16%)